Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Escalon Medical Corp.
  6. Financials
    ESMC   US2960743050

ESCALON MEDICAL CORP.

(ESMC)
Delayed OTC Markets  -  03:39 2022-09-30 pm EDT
0.0922 USD   -0.86%
09/28ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
09/28Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
09/28Escalon Medical Corp. Auditor Raises 'Going Concern' Doubt
CI
SummaryQuotesChartsNewsCompanyFinancialsFunds 
Valuation
Fiscal Period: June 2017 2018 2019 2020 2021 2022
Capitalization1 1,591,740,890,931,560,94
Enterprise Value (EV)1 1,841,050,702,141,681,55
P/E ratio -2,10x3,60x-2,95x-1,32x-15,1x-28,0x
Yield ------
Capitalization / Revenue 0,14x0,15x0,09x0,10x0,15x0,09x
EV / Revenue 0,16x0,09x0,07x0,23x0,16x0,14x
EV / EBITDA -4,03x4,13x-3,45x-2,88x151x-3,68x
Price to Book 1,34x0,96x0,59x1,07x1,91x1,13x
Nbr of stocks (in thousands) 7 5517 5517 4157 4157 4157 415
Reference price (USD) 0,210,230,120,130,210,13
Announcement Date 09/28/201709/28/201809/27/201909/28/202009/27/202109/28/2022
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net sales1 11,211,49,639,4010,510,7
EBITDA1 -0,460,25-0,20-0,740,01-0,42
Operating profit (EBIT)1 -0,500,20-0,25-0,79-0,03-0,47
Operating Margin -4,47%1,80%-2,63%-8,45%-0,32%-4,39%
Pre-Tax Profit (EBT)1 -0,730,58-0,25-0,65-0,050,02
Net income1 -0,730,58-0,25-0,65-0,050,02
Net margin -6,47%5,12%-2,60%-6,92%-0,50%0,17%
EPS2 -0,100,06-0,04-0,09-0,010,00
Dividend per Share ------
Announcement Date 09/28/201709/28/201809/27/201909/28/202009/27/202109/28/2022
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net Debt1 0,25--1,220,120,61
Net Cash position1 -0,690,19---
Leverage (Debt / EBITDA) -0,55x-2,71x0,94x-1,63x10,9x-1,45x
Free Cash Flow1 -0,250,33-0,36-0,070,82-0,83
ROE (Net Profit / Equities) -47,0%32,5%-10,9%-35,4%-3,50%1,23%
Shareholders' equity1 1,551,802,291,841,491,47
ROA (Net Profit / Asset) -5,97%2,46%-3,00%-9,16%-0,37%-5,41%
Assets1 12,223,78,357,1014,1-0,33
Book Value Per Share2 0,160,240,200,120,110,11
Cash Flow per Share2 0,070,120,060,110,220,08
Capex1 0,010,030,020,060,01-
Capex / Sales 0,07%0,26%0,23%0,64%0,09%-
Announcement Date 09/28/201709/28/201809/27/201909/28/202009/27/202109/28/2022
1 USD in Million
2 USD
Key data
Capitalization (USD) 683 693
Net sales (USD) 10 703 070
Number of employees 41
Sales / Employee (USD) 261 050
Free-Float 98,1%
Free-Float capitalization (USD) 670 685
Avg. Exchange 20 sessions (USD) 210
Average Daily Capital Traded 0,03%
EPS & Dividend